GenNBio Past Earnings Performance
Past criteria checks 0/6
GenNBio has been growing earnings at an average annual rate of 3.5%, while the Healthcare industry saw earnings growing at 13.2% annually. Revenues have been declining at an average rate of 14.8% per year.
Key information
3.5%
Earnings growth rate
28.5%
EPS growth rate
| Healthcare Industry Growth | 34.2% |
| Revenue growth rate | -14.8% |
| Return on equity | -25.0% |
| Net Margin | -618.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How GenNBio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,692 | -16,650 | 10,575 | 327 |
| 31 Dec 23 | 5,289 | -15,670 | 12,995 | 561 |
| 30 Sep 23 | 7,521 | -23,380 | 14,402 | 1,000 |
| 30 Jun 23 | 9,324 | -24,876 | 15,279 | 1,414 |
| 31 Mar 23 | 9,910 | -22,880 | 12,412 | 1,620 |
| 31 Dec 22 | 9,373 | -23,023 | 10,641 | 1,502 |
| 30 Sep 22 | 8,765 | -26,828 | 9,440 | 1,318 |
| 30 Jun 22 | 8,502 | -23,677 | 8,298 | 1,032 |
| 31 Mar 22 | 8,081 | -23,008 | 9,141 | 975 |
| 31 Dec 21 | 8,314 | -23,797 | 9,944 | 1,113 |
| 30 Sep 21 | 9,240 | -14,617 | 11,374 | 1,427 |
| 30 Jun 21 | 10,147 | -15,158 | 12,846 | 739 |
| 31 Mar 21 | 10,984 | -17,280 | 12,350 | 673 |
| 31 Dec 20 | 11,846 | -17,025 | 12,772 | 653 |
| 30 Sep 20 | 6,742 | -23,095 | 12,303 | 0 |
| 30 Jun 20 | 8,408 | -5,038 | 13,419 | 426 |
| 31 Mar 20 | 8,380 | -36,777 | 14,891 | 249 |
| 31 Dec 19 | 11,863 | -36,736 | 14,022 | 0 |
| 30 Sep 19 | 16,650 | -24,916 | 11,701 | 0 |
| 30 Jun 19 | 14,404 | -39,190 | 8,177 | 0 |
| 31 Mar 19 | 12,791 | -6,795 | 4,603 | 0 |
| 31 Dec 18 | 7,043 | -5,149 | 4,028 | 0 |
| 30 Sep 18 | 7,534 | -4,183 | 2,885 | 0 |
| 30 Jun 18 | 12,351 | -1,555 | 3,127 | 0 |
| 31 Mar 18 | 15,297 | 1,098 | 3,810 | 0 |
| 31 Dec 17 | 18,183 | 3,574 | 3,446 | 0 |
| 30 Sep 17 | 17,827 | -125 | 2,820 | 131 |
| 30 Jun 17 | 12,322 | -3,342 | 2,284 | 269 |
| 31 Mar 17 | 491 | -4,787 | 810 | 375 |
| 31 Dec 16 | 6,615 | -5,870 | 792 | 469 |
| 30 Sep 16 | -34,592 | 3,485 | 1,466 | -503 |
| 30 Jun 16 | -10,322 | -1,388 | 2,090 | -369 |
| 31 Mar 16 | 22,786 | -7,357 | 5,112 | -90 |
| 31 Dec 15 | 43,003 | -14,399 | 6,731 | 223 |
| 30 Sep 15 | 110,977 | -36,181 | 12,700 | 1,429 |
| 30 Jun 15 | 107,355 | -39,027 | 13,905 | 1,536 |
| 31 Mar 15 | 107,468 | -41,757 | 16,207 | 1,533 |
| 31 Dec 14 | 133,469 | -33,997 | 16,438 | 1,477 |
| 30 Sep 14 | 155,019 | -22,347 | 13,907 | 1,356 |
| 30 Jun 14 | 188,285 | -10,501 | 13,747 | 1,278 |
| 31 Mar 14 | 230,110 | 1,178 | 11,708 | 1,121 |
| 31 Dec 13 | 232,367 | -2,142 | 11,037 | 1,022 |
| 30 Sep 13 | 231,859 | -1,671 | 7,609 | 980 |
| 30 Jun 13 | 245,221 | -3,458 | 7,314 | 803 |
Quality Earnings: A072520 is currently unprofitable.
Growing Profit Margin: A072520 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A072520 is unprofitable, but has reduced losses over the past 5 years at a rate of 3.5% per year.
Accelerating Growth: Unable to compare A072520's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A072520 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (4.2%).
Return on Equity
High ROE: A072520 has a negative Return on Equity (-25.02%), as it is currently unprofitable.